Emicizumab
Names
[ CAS No. ]:
1610943-06-0
[ Name ]:
Emicizumab
Biological Activity
[Description]:
Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research[1].
[Related Catalog]:
[In Vivo]
Emicizumab (1.5-10 mg/kg，静脉注射，尾夹出血前 24 小时)部分纠正血友病a型出血模型中的失血，FVIII 等效为 9 U/dL[1]。 Emicizumab (3 mg /kg, 静脉注射) 联合低剂量 FVIII (10 U/dL) 时可提供额外的止血活性[1]。 Animal Model: FVIII-deficient mice[1] Dosage: 1.5-10 mg/kg Administration: IV, 24 hours before tail-clip bleeding was performed Result: Significantly reduced blood loss in a tail-clip-bleeding model using FVIII-deficient mice.
[References]
Chemical & Physical Properties
No Any Chemical & Physical Properties
Related Compounds
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.